Overview
Kent Shih is a Hematologist Oncology specialist and a Hematologist in Nashville, Tennessee. Dr. Shih is rated as an Experienced provider by MediFind in the treatment of Primary Lymphoma of the Brain. His top areas of expertise are Glioblastoma, Glioma, Metastatic Brain Tumor, Bone Graft, and Vertebroplasty. Dr. Shih is currently accepting new patients.
His clinical research consists of co-authoring 24 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- OTHER MEDICARE
- OTHER MEDICARE PART D
- EPO
- HMO
- PPO
- MEDICARE MAPD
- OTHER MEDICARE
- HMO
- MEDICARE MAPD
- MEDICARE PDP
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- MANAGED MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MANAGED MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- EPO
- HMO
- PPO
- EPO
- HMO
- INDEMNITY
- PPO
- OTHER COMMERCIAL
- EPO
- HMO
- POS
- PPO
- EPO
- PPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
4220 Harding Pike, Nashville, TN 37205
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
1 Clinical Trials
Vanderbilt Health Clinicians, LLC
David Morgan is a Hematologist Oncology specialist and an Oncologist in Nashville, Tennessee. Dr. Morgan is rated as a Distinguished provider by MediFind in the treatment of Primary Lymphoma of the Brain. His top areas of expertise are Large-Cell Immunoblastic Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), Follicular Lymphoma, Small Lymphocytic Lymphoma (SLL), and Bone Marrow Aspiration. Dr. Morgan is currently accepting new patients.
Tristar Bone Marrow Transplant, LLC
Stephen Strickland is a Hematologist and a Hematologist Oncology provider in Nashville, Tennessee. Dr. Strickland is rated as a Distinguished provider by MediFind in the treatment of Primary Lymphoma of the Brain. His top areas of expertise are Acute Myeloid Leukemia (AML), Acute Myeloblastic Leukemia without Maturation, Childhood Acute Myeloid Leukemia, Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Strickland is currently accepting new patients.
Sarah Cannon Research Institute
Dr. Patel joined SCRI in 2024, as director of lymphoma research, and oversees SCRI’s comprehensive lymphoma clinical trial portfolio. Previously, he served as the Director of Hematologic Malignancies and Cell Therapy at the Swedish Cancer Institute in Seattle, Washington, where he led development of the program’s clinical standards for lymphoma care, assisted in the expansion of cell therapy services, and helped shape lymphoma research efforts. Dr. Patel was also a member of the Paul G. Allen Research Center at Seattle Cancer Institute, serving as a co-founding member of the Center for Immuno-oncology, where he collaborated on translational research related to immunotherapy in hematologic diseases.Dr. Patel has been published in various medical journals, including New England Journal of Medicine, Blood, and Journal of Clinical Oncology. He is also a member of the ASCO Cancer Communications Committee, the CIBMTR Lymphoma Working Committee, and the National Planning Committee for the Lymphoma Research Foundation Lymphoma Rounds. His clinical and research focus is in lymphomas, CLL, and cellular therapy. Dr. Patel is rated as a Distinguished provider by MediFind in the treatment of Primary Lymphoma of the Brain. His top areas of expertise are Follicular Lymphoma, Non-Hodgkin Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), Bone Marrow Transplant, and Bone Marrow Aspiration.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- AstrocytomaDr. Shih isDistinguished. Learn about Astrocytoma.
- Atypical Teratoid Rhabdoid Tumor (ATRT)Dr. Shih isDistinguished. Learn about Atypical Teratoid Rhabdoid Tumor (ATRT).
- Brain TumorDr. Shih isDistinguished. Learn about Brain Tumor.
- Embryonal Tumor with Multilayered Rosettes
- EpendymomaDr. Shih isDistinguished. Learn about Ependymoma.
- Familial Pancreatic CancerDr. Shih isDistinguished. Learn about Familial Pancreatic Cancer.
- Advanced
- AgranulocytosisDr. Shih isAdvanced. Learn about Agranulocytosis.
- AngiosarcomaDr. Shih isAdvanced. Learn about Angiosarcoma.
- Breast CancerDr. Shih isAdvanced. Learn about Breast Cancer.
- Carcinoid SyndromeDr. Shih isAdvanced. Learn about Carcinoid Syndrome.
- Childhood Iron Deficiency Anemia
- Chronic Familial NeutropeniaDr. Shih isAdvanced. Learn about Chronic Familial Neutropenia.
- Experienced
- Acute Mountain SicknessDr. Shih isExperienced. Learn about Acute Mountain Sickness.
- Adult Immune ThrombocytopeniaDr. Shih isExperienced. Learn about Adult Immune Thrombocytopenia.
- Adult Soft Tissue SarcomaDr. Shih isExperienced. Learn about Adult Soft Tissue Sarcoma.
- ALK-Positive Non-Small Cell Lung Cancer
- Alveolar Soft Part SarcomaDr. Shih isExperienced. Learn about Alveolar Soft Part Sarcoma.
- Ampullary CancerDr. Shih isExperienced. Learn about Ampullary Cancer.